Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion type Assertion NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_head.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_provenance.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion evidence source_evidence_literature NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_provenance.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion SIO_000772 15590749 NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_provenance.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion wasDerivedFrom gad-20150221 NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_provenance.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion wasGeneratedBy ECO_0000203 NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_provenance.